Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rudy van Eijsden"'
Autor:
Olivier Govaere, Werner Van Steenbergen, Frederik Nevens, Simon Cockell, Rudy van Eijsden, Jasper Wouters, Matthias Van Haele, Arianna Bianchi, Diethard Monbaliu, Wouter Van Delm, Kathleen Van den Eynde, Tania Roskams
Publikováno v:
The Journal of pathology. 248(1)
Ductular reaction (DR) represents the activation of hepatic progenitor cells (HPCs) and has been associated with features of advanced chronic liver disease; yet it is not clear whether these cells contribute to disease progression and how the composi
Autor:
Freddy R. Delvaux, Sebastiaan E. Van Mulders, Bart Devreese, Ronnie Willaert, Rudy van Eijsden, Luk Daenen, Catherine Stassen, Verena Siewers, Jens Nielsen
Publikováno v:
ASTROBIOLOGY
Vrije Universiteit Brussel
Vrije Universiteit Brussel
This study investigates the effects of microgravity on colony growth and the morphological transition from single cells to short invasive filaments in the model eukaryotic organism Saccharomyces cerevisiae. Two-dimensional spreading of the yeast colo
Autor:
Sandrine Marreaud, Ron H.J. Mathijssen, Raf Sciot, Rudy van Eijsden, Stefan Sleijfer, Marcel Smid, Agnieszka Wozniak, Axelle Nzokirantevye, Erik A.C. Wiemer, Patrick Schöffski, Joke Allemeersch, Herman Burger, Giuseppe Floris
Publikováno v:
Journal of Clinical Oncology. 31:10573-10573
10573 Background: The phase II study EORTC 62052 demonstrated potential antitumor activity of eribulin, a tubulin-interacting cytotoxic agent, which is a synthetic analogue of the natural compound halichondrin B, in patients with various subtypes of
Autor:
Louis Libbrecht, Jos van Pelt, Petra Windmolders, Hannah van Malenstein, Rudy van Eijsden, Frederik Nevens, Jeroen Dekervel, Chris Verslype
Publikováno v:
Journal of Clinical Oncology. 30:216-216
216 Background: Sorafenib, a multi tyrosine kinase inhibitor, is the first line treatment in patients with advanced hepatocellular carcinoma (HCC). It leads to a survival benefit but treatment with sorafenib is hampered by two phenomena: patients can
Publikováno v:
BMC Cancer
Background Most cancer deaths are caused by metastases, resulting from circulating tumor cells (CTC) that detach from the primary cancer and survive in distant organs. The aim of the present study was to develop a CTC gene signature and to assess its
Autor:
Jens Nielsen, Luk Daenen, Ingeborg Stals, Francesco Ielasi, Bart Devreese, Rudy van Eijsden, Freddy R. Delvaux, Catherine Stassen, Livan Alonso-Sarduy, Sandor Kasas, Verena Siewers, Sebastiaan E. Van Mulders, Ronnie Willaert, Intawat Nookaew, Katty V. Y. Goossens
Publikováno v:
mBio, Vol 6, Iss 2 (2015)
mBio
mBio
We studied the flocculation mechanism at the molecular level by determining the atomic structures of N-Flo1p and N-Lg-Flo1p in complex with their ligands. We show that they have similar ligand binding mechanisms but distinct carbohydrate specificitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720b9ada2bf6948bf6a1d49309cd41e2
https://infoscience.epfl.ch/record/212450
https://infoscience.epfl.ch/record/212450
Autor:
Luk Daenen, Ronnie Willaert, Sebastiaan E. Van Mulders, Bart Devreese, Rudy van Eijsden, Verena Siewers, Catherine Stassen, Prashant Madhusudhan Bapat, Freddy R. Delvaux, Paul Van Hummelen, Jens Nielsen, Katty V. Y. Goossens
Publikováno v:
Vrije Universiteit Brussel
Genomics, transcriptomics, proteomics and fluxomics are powerful omics-technologies that play a major role in today's research. For each of these techniques good sample quality is crucial. Major factors contributing to the quality of a sample is the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c2844a9a224a7a5e776bc57cdb76ac7
https://researchportal.vub.be/en/publications/0bc47e88-c60e-441e-a458-b908bd405635
https://researchportal.vub.be/en/publications/0bc47e88-c60e-441e-a458-b908bd405635
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 31, Iss 1, p 68 (2012)
Journal of Experimental & Clinical Cancer Research, Vol 31, Iss 1, p 68 (2012)
Background Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous cancer in which differences in survival rates might be related to a variety in gene expression profiles. Although the molecular biology of PDAC begins to be revealed, genes or path